BCLSI
REPL icon

Bain Capital Life Sciences Investors’s Replimune Group REPL Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,122,415
Closed -$48.9M – 27
2020
Q3 		$48.9M Sell
2,122,415
-40,183
-2% -$916K 4.55% 6
2020
Q2 		$53.7M Sell
2,162,598
-676,370
-24% -$12M 5.63% 6
2020
Q1 		$28.3M Hold
2,838,968
– – 4.79% 6
2019
Q4 		$40.7M Hold
2,838,968
– – 6.08% 5
2019
Q3 		$39.5M Hold
2,838,968
– – 10.16% 4
2019
Q2 		$41.6M Hold
2,838,968
– – 21.14% 2
2019
Q1 		$43.2M Hold
2,838,968
– – 17.28% 2
2018
Q4 		$28.4M Hold
2,838,968
– – 9.7% 5
2018
Q3 		$45.7M Buy
+2,838,968
New +$49.8M 10.37% 5

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return